159 related articles for article (PubMed ID: 26961557)
1. Long-term survival in a patient with brain metastases of papillary thyroid carcinoma.
Guelho D; Ribeiro C; Melo M; Carrilho F
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26961557
[TBL] [Abstract][Full Text] [Related]
2. Euthyroid status after total thyroidectomy due to functioning lung metastases from a clear cell variant of papillary thyroid carcinoma.
Lee JI; Chung YJ; Park SJ; Ryu HS; Cho BY
Thyroid; 2012 Oct; 22(10):1084-7. PubMed ID: 22873179
[TBL] [Abstract][Full Text] [Related]
3. A rare case report of very low thyroglobulin and a negative whole-body scan in a patient with a solid variant of papillary thyroid carcinoma with distant metastases.
Li W; Sun D; Ming H; Zhang G; Tan J
Medicine (Baltimore); 2017 Feb; 96(7):e6086. PubMed ID: 28207517
[TBL] [Abstract][Full Text] [Related]
4. Noninferior response in BRAF(V600E) mutant nonmetastatic papillary thyroid carcinoma to radioiodine therapy.
Li J; Liang J; Zhao T; Lin Y
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1034-9. PubMed ID: 26780618
[TBL] [Abstract][Full Text] [Related]
5. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
[TBL] [Abstract][Full Text] [Related]
6. Papillary thyroid carcinoma with brain metastases: an unusual 10-year-survival case.
Miranda ER; Padrão EL; Silva BC; De Marco L; Sarquis MS
Thyroid; 2010 Jun; 20(6):657-61. PubMed ID: 20470207
[TBL] [Abstract][Full Text] [Related]
7. The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.
Daliri M; Abbaszadegan MR; Bahar MM; Arabi A; Yadollahi M; Ghafari A; Taghehchian N; Zakavi SR
Endocr Res; 2014; 39(4):189-93. PubMed ID: 24679337
[TBL] [Abstract][Full Text] [Related]
8. [Seven cases of brain metastasis from papillary thyroid carcinoma].
Ikekubo K; Hino M; Ito H; Hirao K; Ueshima M; Tanaka T; Kobayashi H; Ishihara T; Kurahachi H
Kaku Igaku; 2000 Jul; 37(4):349-57. PubMed ID: 10965656
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic metastasis arising from a BRAF(V600E)-positive papillary thyroid cancer: the role of endoscopic ultrasound-guided biopsy and response to sorafenib therapy.
Alzahrani AS; AlQaraawi A; Al Sohaibani F; Almanea H; Abalkhail H
Thyroid; 2012 May; 22(5):536-41. PubMed ID: 22435913
[TBL] [Abstract][Full Text] [Related]
10. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
[TBL] [Abstract][Full Text] [Related]
11. Persistent and recurrent disease in patients with papillary thyroid carcinoma with clinically apparent (cN1), but not extensive, lymph node involvement and without other factors for poor prognosis.
Furtado Mde S; Rosario PW; Calsolari MR
Arch Endocrinol Metab; 2015 Aug; 59(4):285-91. PubMed ID: 26331314
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected "recurrent" neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy.
Hay ID; Lee RA; Davidge-Pitts C; Reading CC; Charboneau JW
Surgery; 2013 Dec; 154(6):1448-54; discussion 1454-5. PubMed ID: 24176579
[TBL] [Abstract][Full Text] [Related]
13. Thyroid follicular carcinoma metastasized to the lung, skull, and brain 12 years after initial treatment for thyroid gland--case report.
Ogawa Y; Sugawara T; Seki H; Sakuma T
Neurol Med Chir (Tokyo); 2006 Jun; 46(6):302-5. PubMed ID: 16794352
[TBL] [Abstract][Full Text] [Related]
14. [Differentiated thyroid cancer in childhood].
Leboulleux S; Hartl D; Baudin E; Schlumberger M
Bull Cancer; 2012 Nov; 99(11):1093-9. PubMed ID: 23149302
[TBL] [Abstract][Full Text] [Related]
15. Treatment with sorafenib in advanced thyroid cancer - a case report.
Krajewska J; Olczyk T; Roskosz J; Paliczk-Cieślik E; Smietana AK; Kaczmarek-Borowska B; Jarząb B
Endokrynol Pol; 2010; 61(5):492-6. PubMed ID: 21049464
[TBL] [Abstract][Full Text] [Related]
16. Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management--A Case Report.
Shrestha RT; Karunamurthy A; Amin K; Nikiforov YE; Caramori ML
Thyroid; 2015 Dec; 25(12):1375-8. PubMed ID: 26355276
[TBL] [Abstract][Full Text] [Related]
17. Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenib.
Rothenberg SM; McFadden DG; Palmer EL; Daniels GH; Wirth LJ
Clin Cancer Res; 2015 Mar; 21(5):1028-35. PubMed ID: 25549723
[TBL] [Abstract][Full Text] [Related]
18. Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.
O'Neill CJ; Coorough N; Lee JC; Clements J; Delbridge LW; Sippel R; Sywak MS; Chen H; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):240-4. PubMed ID: 23316684
[TBL] [Abstract][Full Text] [Related]
19. Distant, solitary skeletal muscle metastasis in recurrent papillary thyroid carcinoma.
Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Choe JH; Kim JH; Kim JS
Thyroid; 2011 Sep; 21(9):1027-31. PubMed ID: 21834676
[TBL] [Abstract][Full Text] [Related]
20. Prognostic prediction of BRAF(V600E) and its relationship with sodium iodide symporter in classic variant of papillary thyroid carcinomas.
Gao WL; Wie LL; Chao YG; Wie L; Song TL
Clin Lab; 2012; 58(9-10):919-26. PubMed ID: 23163107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
